DEAL ANNOUNCEMENT / PRESS RELEASE
January 20, 2026
Read time: 3 min
McDermott Will & Schulte advised Sagard NewGen on its minority investment in Quipment, a leading provider of equipment solutions for clinical trials, alongside its founders and management team.
This strategic investment will strengthen the company’s position as a global partner to CROs and sponsors.
The McDermott team comprised:
- Diana Hund, Marie-Muriel Barthelet, partners, Robin Lamour, associate, on corporate aspects
- Emmanuelle Trombe, partner, Caroline Noyrez and Nejma Palasse, associates, on Life Sciences aspects
- Antoine Vergnat, partner, on tax aspects
Leading organizations turn to global law firm McDermott Will & Schulte for a better way to address legal challenges, connect with those at the forefront, and drive stronger outcomes. Working across more than 20 offices globally, our 1,750+ lawyers act on data-driven insights, deep relationships, and unmatched industry experience to deliver on our commitment of Always Better.
